XML 40 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
REORGANIZATION (Tables)
9 Months Ended
Sep. 30, 2022
Restructuring and Related Activities [Abstract]  
Restructuring Costs

On August 23, 2022, we announced the temporary suspension of operations at our Rock Hill Facility, shifting related manufacturing to our Calgary manufacturing facility.

Reorganization costs incurred:

 

 

 

For the Three Months Ended

 

 

For the Nine Months Ended

 

 

 

September 30, 2022

 

 

September 30, 2022

 

 Termination benefits

 

 

2,843

 

 

 

6,870

 

 Insurance costs on change of control

 

 

-

 

 

 

3,676

 

 Phoenix Facility closure

 

 

-

 

 

 

853

 

 Rock Hill temporary suspension of operations

 

 

144

 

 

 

144

 

 Other costs

 

 

439

 

 

 

738

 

 Total reorganization costs

 

 

3,426

 

 

 

12,281

 

 

 

 

 

 

 

 

 

 

For the Three Months Ended

 

 

For the Nine Months Ended

 

 

 

September 30, 2022

 

 

September 30, 2022

 

 Opening reorganization costs in accounts payable and accrued liabilities

 

 

1,555

 

 

 

-

 

 Reorganization expense

 

 

3,426

 

 

 

12,281

 

 Reorganization costs paid

 

 

(3,228

)

 

 

(10,528

)

 Reorganization costs in accounts payable and accrued liabilities at September 30, 2022

 

 

1,753

 

 

 

1,753

 

Phoenix Facility Restructuring Costs the Company accelerated the depreciation of certain items of property, plant and equipment associated with the closure of the Phoenix Facility resulting in an additional $1.1 million of depreciation and amortization incurred in the first quarter of 2022.

These costs were included in cost of sales:

 

 

 

For the Three Months Ended

 

 

For the Nine Months Ended

 

 

 

September 30, 2022

 

 

September 30, 2022

 

 Accelerated depreciation and amortization associated with closure of the Phoenix Facility

 

 

-

 

 

 

1,054

 

 Accelerated amortization associated with product line discontinuation

 

 

1,019

 

 

 

1,019

 

 Provision for inventory of discontinued product lines

 

 

1,035

 

 

 

1,035

 

 Incremental cost of sales

 

 

2,054

 

 

 

3,108